Diagnosis and treatment of cutaneous zygomycosis

Pediatric Infectious Disease Journal

Volumn 26, Issue 12, 2007, Pages 1165-1166

  Visser, Douwe H ^a   Van Den Berg, Yvette L F ^b   Van Furth, A Marceline ^a   Oomen, Matthijs W ^b   Schouten van Meeteren, Antoinette Y N ^a,b   Pajkrt, Dasja ^b   Van Den Bos, Cor ^b   Van Well, Gijs Th J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Cutaneous; Liposomal amphotericin B; Surgery; Zygomycetes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; FLUCLOXACILLIN; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; TOBRAMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASPERGILLUS; BACTERIAL SKIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; FUNGUS HYPHAE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERBARIC OXYGEN; MALE; MICROSCOPY; MUCORMYCOSIS; NECROTIZING FASCIITIS; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS PUTIDA; RELAPSE; SCHOOL CHILD; SKIN BIOPSY; SKIN CULTURE; SKIN TRANSPLANTATION; STAPHYLOCOCCUS INFECTION; TISSUE CULTURE;

EID: 36549007585     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181462a4b     Document Type: Article

References (10)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634-653.
2. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am. 2002;16:895-914.
3. Oh D, Notrica D. Primary cutaneous mucormycosis in infants and neonates: case report and review of the literature. J Pediatr Surg. 2002;37:1607-1611.
4. Bialek R, Konrad F, Kern J, et al. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol. 2005;58:1180-1184.
5. Imhof A, Balajee SA, Fredricks DN, et al. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 2004;39:743-746.
6. Morales-Aguirre JJ, Agüero-Echeverria WM, Ornelas-Carsoloi ME, et al. Successful treatment of a primary cutaneous zygomycosis caused by Absidia corymbifera in a premature newborn. Pediatr Infect Dis J. 2004;23:470-472.
7. Barratt DM, Meter van K, Asmar P, et al. Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrob Agents Chemother. 2001;45:3601-3602.
8. Walsh TJ, Seibel NL, Arndt C, et al. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J. 1999;18:702-708.
9. Page RL II, Schwiesow J, Hilts A. Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. Pharmacotherapy. 2007;27:290-298.
10. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis. 1997;24:192-196.